Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.
- Jason Martinez begins as IDX CEO on 6 August 2026
- Martinez has 20+ years in diagnostic imaging and healthcare
- Outgoing CEO Ian Kadish retires after a decade at the helm
- FY26 audited results presentation scheduled for 25 August 2026
- Focus on growth, clinical excellence, and innovation
New CEO Jason Martinez Takes the Helm at Integral Diagnostics
Integral Diagnostics (ASX:IDX) has officially welcomed Jason Martinez as its new Managing Director and Chief Executive Officer, commencing his role on 6 August 2026. The appointment concludes a carefully managed leadership transition following Martinez’s appointment announcement in November 2025. Martinez arrives with over two decades of experience in diagnostic imaging and healthcare, most recently as Executive General Manager at I-MED Radiology, where he led significant acquisitions and operational growth across multiple states.
Experienced Leadership Aims to Build on Strong Foundations
Martinez’s track record includes driving business expansion, improving efficiency, and enhancing engagement with patients and radiologists. He expressed enthusiasm about steering IDX’s next chapter, highlighting the company’s international reach and radiologist-led culture as key strengths. His stated priorities include unlocking higher quality care for patients and advancing growth, signaling a strategic focus that blends clinical excellence with innovation.
Farewell to a Decade of Steadfast Leadership
The leadership handover also marks the retirement of Dr Ian Kadish, who has served as CEO for over ten years. IDX Chair Toby Hall praised Kadish’s decade of dedication, vision, and transformative stewardship, noting his role in guiding the company through significant growth and change while maintaining a patient-first focus. Kadish’s support during the transition has been described as invaluable, underscoring a smooth changeover in leadership.
Upcoming Financial Results and Investor Engagement
Martinez will soon share the stage with CFO Craig White to present IDX’s audited FY26 financial results on 25 August 2026. This event will offer the first opportunity for investors to gauge the new CEO’s strategic direction against the backdrop of the company’s recent performance. While the filing does not disclose specific guidance or strategic initiatives, the market will be watching for signals on growth prospects and operational priorities under Martinez’s leadership.
Bottom Line?
The new CEO’s extensive sector experience sets the stage for a potentially dynamic phase at IDX, but investors will be keen to see how this translates into tangible growth and innovation in the near term.
Questions in the middle?
- How will Jason Martinez’s leadership style influence IDX’s strategic priorities beyond growth?
- What operational changes might accompany the leadership transition in the diagnostic imaging sector?
- Will the FY26 results presentation provide clarity on Martinez’s vision for innovation and market expansion?